Brief: Orexo Posts Data From Modia Study On Impact On Use Of Illicit Opioids

Orexo AB

11/10/2023 07:23

Oct 11 (Reuters) - Orexo AB  ORX.ST :
    * OREXO ANNOUNCES DATA FROM THE MODIA® STUDY EVALUATING
IMPACT ON
USE OF ILLICIT OPIOIDS
    * STUDY DEMONSTRATED NO STATISTICALLY SIGNIFICANT DIFFERENCE
BETWEEN TREATMENT ARMS IN ANY PRE-SPECIFIED ENDPOINT
    * BOTH TREATMENT ARMS HAD UNEXPECTEDLY HIGH RATES OF
TREATMENT
RESPONSE, WITH NO ADVERSE EVENTS ASSOCIATED WITH USE OF MODIA
    * POST HOC ANALYSIS FOUND THAT PATIENTS COMPLETING ALL 24
MODULES
OF MODIA HAD A SIGNIFICANTLY HIGHER TREATMENT RESPONSE THAN
THOSE WHO DID NOT COMPLETE ENTIRE PROGRAM
    * WILL CONTINUE TO COMMERCIALIZE MODIA AS A MOBILE MEDICAL
DEVICE
SUBJECT TO FDA ENFORCEMENT DISCRETION
    * IN STUDY 38% OF PATIENTS REPORTED AT LEAST ONE ADVERSE
EVENT

Source text for Eikon:  ID:nWkr6gFWH8 
Further company coverage:  ORX.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;;))